Potential shortcut in antibiotics development
A minimal – and therefore innocuous – dose of an antibiotic coupled with highly sensitive measurement technology could save time and money in the development of new active ingredients. The shortcut lies in being able to do pharmacokinetic testing earlier, which consists in establishing proof that the potentially antibacterial agent can actually become effective at […] Continue reading “Potential shortcut in antibiotics development”